Veracyte, Inc. financial data

Symbol
VCYT on Nasdaq
Industry
Services-Medical Laboratories
Location
6000 Shoreline Court, Suite 300, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CALDEROME INC (to 2/27/2008)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 480 % +4.57%
Quick Ratio 28.5 % +16.7%
Debt-to-equity 8.83 % +27.1%
Return On Equity 2.1 %
Return On Assets 1.93 %
Operating Margin 3.62 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.9M shares +1.96%
Common Stock, Shares, Outstanding 77.8M shares +6.15%
Entity Public Float 1.5B USD -11.8%
Common Stock, Value, Issued 78K USD +6.85%
Weighted Average Number of Shares Outstanding, Basic 76.5M shares +5.29%
Weighted Average Number of Shares Outstanding, Diluted 78.2M shares +7.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 446M USD +23.5%
Research and Development Expense 69.3M USD +20.9%
Selling and Marketing Expense 95.4M USD -5.97%
General and Administrative Expense 111M USD +28.3%
Costs and Expenses 282M USD -10.6%
Operating Income (Loss) 16.1M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 25.7M USD
Income Tax Expense (Benefit) -44K USD
Net Income (Loss) Attributable to Parent 24.1M USD
Earnings Per Share, Basic 0.32 USD/shares
Earnings Per Share, Diluted 0.31 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 239M USD +10.5%
Cash, Cash Equivalents, and Short-term Investments 289M USD +33.7%
Accounts Receivable, after Allowance for Credit Loss, Current 46.5M USD +15.2%
Inventory, Net 21.8M USD +34.9%
Assets, Current 372M USD +30.3%
Operating Lease, Right-of-Use Asset 48.2M USD +369%
Intangible Assets, Net (Excluding Goodwill) 102M USD +15.5%
Goodwill 746M USD +6.09%
Other Assets, Noncurrent 6.98M USD +16.9%
Assets 1.3B USD +16.6%
Accounts Payable, Current 8.63M USD -33.3%
Employee-related Liabilities, Current 30.6M USD +15.8%
Accrued Liabilities, Current 43.8M USD +14.1%
Contract with Customer, Liability, Current 1.67M USD -16.7%
Liabilities, Current 78.6M USD +28.4%
Deferred Income Tax Liabilities, Net 1.23M USD +67.2%
Operating Lease, Liability, Noncurrent 43.2M USD +475%
Other Liabilities, Noncurrent 411K USD -47.7%
Liabilities 124M USD +75.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -36.1M USD -50.3%
Retained Earnings (Accumulated Deficit) -444M USD +5.16%
Stockholders' Equity Attributable to Parent 1.18B USD +12.6%
Liabilities and Equity 1.3B USD +16.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.97M USD -313%
Net Cash Provided by (Used in) Financing Activities -864K USD -151%
Net Cash Provided by (Used in) Investing Activities 2.88M USD -88%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 77.8M shares +6.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.06M USD -130%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 241M USD +10.7%
Deferred Tax Assets, Gross 262M USD +60.9%
Operating Lease, Liability 50.7M USD +302%
Payments to Acquire Property, Plant, and Equipment 2.13M USD +115%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12.1M USD +46.5%
Lessee, Operating Lease, Liability, to be Paid 94.6M USD +577%
Operating Lease, Liability, Current 7.5M USD +46.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.73M USD -0.05%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.01M USD +41.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +37.5%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 43.8M USD +3180%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.34M USD +490%
Deferred Tax Assets, Operating Loss Carryforwards 184M USD +65.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 7.18M USD +26.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.51M USD +1335%
Operating Lease, Payments 7.18M USD +33.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 14.8M USD -28.2%
Depreciation, Depletion and Amortization 5.59M USD -16.2%
Deferred Tax Assets, Net of Valuation Allowance 34M USD +48.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%